Other

 In October, scientists set out to do something unprecedented – conduct a drugs trial during an epidemic to find a treatment for a lethal disease. Could they make history and change the way we deal with outbreaks?

THE GUARDIAN  by Sarah Boseley                           Feb, 17, 2015

In depth description of efforts by a group of Oxford University scientists to run field trials of drugs for use against Ebola.

" ...The little band of scientists had flown to Guinea on 16 October to do something that had never been successfully done before – set up a trial of experimental drugs against an infectious disease in the middle of an epidemic. Because the Ebola virus does not exist at low levels in any population, unless you run a properly conducted trial while the storm is raging, you will never have drugs that are proven to be effective. The Oxford team’s trial would not only aim to find a drug that worked against Ebola but also to establish a blueprint for the way drug trials would be run during outbreaks in the future. This did not just apply to fighting Ebola: if the scientists were successful, their trial would develop protocols for testing drugs for any epidemic, be it Sars or flu...."

Read complete story.

WASHINGTON POST by Juliet Eilperin and Steven Mufson                             Feb. 13, 2015

WASHINGTON --If there is to be war, the fight against Ebola is President Obama’s type of war. The enemy fires no bullets and carries no bombs; it doesn’t use social media to recruit fighters and rally supporters. And the fighting can best be done by intelligent professionals who don’t try to kill people, but to save them.

On Wednesday, Obama celebrated the progress against the deadly virus since the administration launched a military and civilian effort in September. While the president emphasized it was too soon to declare “mission accomplished” — as President George W. Bush did about Iraq in 2003 — Obama said “we’re shifting our focus from fighting the epidemic to now extinguishing it.”

An ambulance transports the author to the Nebraska Medical Center in October. (Sait Serkan Gurbuz/Reuters)

THE ATLANTIC by Ashoka Mukpo                                                                          Feb. 12, 2015

Like the majority of patients taken to Western hospitals, I recovered from the disease—but health authorities are still struggling to figure out how to bring up the much-lower survival rate in West Africa.

...the 80-percent survival rate among patients who were evacuated to Western hospitals shattered the idea that an Ebola diagnosis spelled near-certain death. I know this all too well, as I’m one of those patients myself. In October, I contracted Ebola while covering the outbreak as a freelance journalist in Liberia. I was airlifted to a hospital in Nebraska, where aggressive treatment likely saved my life....
Read complete story.

http://www.theatlantic.com/health/archive/2015/02/why-didnt-ebola-kill-me/385335/

INTERNATIONAL BUSINESS NEWS by Jayalaksmi K      Feb. 2, 2015

A common virus that infects billions at some point of their lives is believed to deliver some protection against other deadlier viruses like HIV and Ebola.

David O'Connor, a pathology professor at the University of Wisconsin in Madison, found the genetic fingerprints of the virus GBV-C in the records of 13 samples of blood plasma from Ebola patients.

While six of the 13 people who were co-infected with Ebola and GBV-C died, seven survived.

Combined with earlier studies that have hinted persistent infection with the virus slowed disease progression in some HIV patients, researchers think the virus could be beneficial.

"We're very cautious about over-interpreting these results," O'Connor told NPR. He is now waiting to get a bigger sample, to see if there really is a strong connection between GBV-C infection and survival.
Read complete story.